|

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

RECRUITINGN/ASponsored by University of Central Florida
Actively Recruiting
PhaseN/A
SponsorUniversity of Central Florida
Started2023-06-09
Est. completion2027-06-30
Eligibility
Age60 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT05838638

Summary

The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.

Eligibility

Age: 60 Years+Healthy volunteers accepted
Inclusion Criteria:

* age 60 or older
* newly diagnosed with cancer
* treatment with any chemotherapeutic agent of moderate or high emetic potential
* on a 2, 3 or 4 week treatment cycle
* proficient in English
* has a telephone

Exclusion Criteria:

* previous diagnosis and/or treatment for cancer
* end stage disease with less than 6 months to live
* visually or hearing impaired without corrective device

Conditions3

CancerChemotherapy Induced Nausea and VomitingNeoplasms

Locations2 sites

Miller School of Medicine Sylvester Comp. Cancer Center
Miami, Florida, 33136
Deborah Anglade, PhDd.anglade@miami.edu
Orlando Health
Orlando, Florida, 32806
Aurea Middleton, MSNaurea.middleton@orlandohealth.com

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.